• 59 Hits
  • Search Condition : Filter (MeSH = Liver Neoplasms / drug therapy*)
Species Resource Title
Human and Animal Cells Hep G2 Phosphorylation of mTOR Ser2481 is a key target limiting the efficacy of rapalogs for treating hepatocellular carcinoma.
Human and Animal Cells OS-RC-2(RCB0735) Growth inhibitory effects of pegylated IFN-alpha2b and 5-fluorouracil in combination on renal cell carcinoma cell lines in vitro and in vivo.
Human and Animal Cells HuH-7(RCB1366) Vitamin K2 suppresses proliferation and motility of hepatocellular carcinoma cells by activating steroid and xenobiotic receptor.
Human and Animal Cells HuH-6(RCB1367) Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
Human and Animal Cells 293T(RCB2202) Treatment of Retinoblastoma 1-Intact Hepatocellular Carcinoma With Cyclin-Dependent Kinase 4/6 Inhibitor Combination Therapy.
Human and Animal Cells Li-7(RCB1941) Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells.
Human and Animal Cells OS-RC-2(RCB0735) Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice.
Human and Animal Cells HuH-7(RCB1366) Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin.
Human and Animal Cells HuH-7 mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.
Human and Animal Cells HuH-7 HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells.
Human and Animal Cells HuH-6(RCB1367) Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish.
Human and Animal Cells Hep G2 The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma.
Human and Animal Cells Hep G2(RCB1886) Heat shock exerts anticancer effects on liver cancer via autophagic degradation of aquaporin 5.
Human and Animal Cells A431 Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.
Human and Animal Cells Li-7(RCB1941) Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma.
Human and Animal Cells Hep G2(RCB1648) Growth inhibition by NVP-BEZ235, a dual PI3K/mTOR inhibitor, in hepatocellular carcinoma cell lines.
Human and Animal Cells HuH-6(RCB1367) MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma.
Human and Animal Cells PANC-1(RCB2095) , MIA Paca2(RCB2094) Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells.
Human and Animal Cells HuH-7 , Hep G2 Photodynamic Diagnosis of Hepatocellular Carcinoma Using 5-Aminolevulinic Acid.
Human and Animal Cells HuH-7 TLR4-mediated pyroptosis in human hepatoma-derived HuH-7 cells induced by a branched-chain polyunsaturated fatty acid, geranylgeranoic acid.